The New York Times reported today that emails released during ongoing congressional hearings about GM’s faulty ignition switches discussed the cost of fixing the switch.
Based on the emails, which were written in 2005, it appears that the cost of the fixing the switch was a factor in why a change was delayed for years. Several people died in accidents caused by ignition switch failures. Because ...
continue reading...After recently recalling 1.6 million Chevrolet Cobalts and Saturn Ions due to a faulty ignition switch that has been linked to numerous accidents, GM stopped sales of 2013 and 2014 Cruzes. The order to stop sales of the vehicle was done without any explanation at the time, but typically signifies a decision to fix a safety issue before a car is sold, thus avoiding a later recall to fix the ...
continue reading...A link has been found between the use of testosterone supplements and heart attacks according to a new study. The study authored by epidemiologist William Finkle and researchers at UCLA found that the risk of heart attack in men 65 and older taking testosterone supplements more than doubled with the first 90 days of using the product. The study found that in men under the age of ...
continue reading...On Wednesday, January 9, 2014, the FDA issued a warning concerning the potential for serious injury from laxatives containing sodium phosphate. Over-the-counter sodium phosphate drugs are used to treat constipation. They come in oral and rectal (enema) form. The recommended dose is one in 24 hours. These over-the-counter laxatives can cause serious kidney and heart injuries, even death, if more than one dose is taken over 24 hours.
The FDA has received reports that ...
continue reading...According to The Hill, two senators are investigating allegations that “members of the pharmaceutical industry” paid large sums of money to meet with FDA officials in connection with its recent approval of Zohydro.
The Hill reports that Senators Joe Manchin, (D-WV) and David Vitter (R-LA) have written letters to the FDA and others who may have been involved. According to the letter, multiple pharmaceutical companies paid $25,000 to $30,000 to a university hospital to meet with FDA ...
continue reading...In October, the FDA approved a new hydrocodone-containing pain medication known as Zohydro Extended Release. This approval has caused some controversy among doctors, pain specialists, and addiction organizations, because, according to CNN, it is five times more powerful than other pain medications. If the predictions that Zohydro will cause injury come to pass, then Zohydro lawsuits are likely in the future.
According to CNN, pain medication abuse is the leading cause of preventable death, responsible for ...
continue reading...
